Hans Schambye is Former President and Chief Executive Officer of Damora Therapeutics, Inc. (DMRA). The company reported total compensation of $1,299,792 for fiscal year 2025.
| Salary | $547,521 |
|---|---|
| Bonus | $678,594 |
| Stock awards | $0 |
| Option awards | $73,677 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $1,299,792 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Damora Therapeutics, Inc. filed April 29, 2026, accession 0001193125-26-191429.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Former President and Chief Executive Officer | $547,521 | $678,594 | $0 | $73,677 | $0 | $0 | $0 | $1,299,792 |
| FY2024 | Former President and Chief Executive Officer | $526,084 | $502,587 | $142,000 | $258,879 | $0 | $0 | $0 | $1,429,550 |
Totals as disclosed in each year's own compensation disclosure for Damora Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Hans Schambye this page | Former President and Chief Executive Officer | $1,299,792 |
| Garrett Winslow | General Counsel | $854,755 |
| Lori Firmani | Chief Financial Officer | $563,211 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Damora Therapeutics, Inc. compensation brief.
Hans Schambye's compensation sits inside Damora Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.